Evidence map›Paper›PMID 23431138›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2013

Related F-box proteins control cell death in Caenorhabditis elegans and human lymphoma.

Michael Chiorazzi, Lixin Rui, Yandan Yang, Michele Ceribelli, Nima Tishbi, Carine W Maurer, Stella M Ranuncolo, Hong Zhao, Weihong Xu, Wing-Chung C Chan and 9 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 71 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Geranylgeranylated SCFCell reports · 2024
    Article
  6. Article
  7. Article
  8. Geranylgeranylated-SCFbioRxiv : the preprint server for biology · 2024
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 10 institutions in 5 countries.

Michael ChiorazziLaboratory of Developmental Genetics, The Rockefeller University, New York, NY 10065, USA.
Lixin Rui
Yandan Yang
Michele Ceribelli
Nima Tishbi
Carine W Maurer
Stella M Ranuncolo
Hong Zhao
Weihong Xu
Wing-Chung C Chan
Elaine S Jaffe
Randy D Gascoyne
Elias Campo
Andreas Rosenwald
German Ott
Jan Delabie
Lisa M Rimsza
Shai Shaham
Louis M Staudt
Center for Cancer Research · USRockefeller University · USNational Cancer Institute · USBC Cancer Agency · CAOslo University Hospital · NORobert Bosch Hospital · DESWOG Cancer Research Network · USUniversitat de Barcelona · ESUniversity of Nebraska at Omaha · USUniversity of Würzburg · DE

Funding

Weill Cornell/Rockefeller/Sloan-Kettering MST ProgramT32GM007739 · NIGMS · WEILL MEDICAL COLL OF CORNELL UNIV · PI HSU, KATHARINE C · 1985 to 2023
$51.1M
Oncogenic mechanisms and molecular targets in lymphomaZIABC011008 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI STAUDT, LOUIS · 2009 to 2025
$21.0M
Lymphoma Disease Discovery and DefintionZIASC000550 · NCI · DIVISION OF CLINICAL SCIENCES - NCI · PI JAFFE, ELAINE · 2009 to 2025
$16.9M
Molecular Signatures to Improve Diagnosis and Outcome PrU01CA114778 · NCI · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI CHAN, WING C. · 2005 to 2009
$8.7M
Developmental control of apoptosis in C.elegansR01HD042680 · NICHD · ROCKEFELLER UNIVERSITY · PI SHAHAM, SHAI · 2002 to 2011
$3.0M
Control of nonapoptotic C. elegans cell death similar to neurodegenerationR01NS081490 · NINDS · ROCKEFELLER UNIVERSITY · PI SHAHAM, SHAI · 2012 to 2017
$2.2M
Role of dre-1/FBXO11 in apoptosisF30AG035484 · NIA · WEILL MEDICAL COLL OF CORNELL UNIV · PI CHIORAZZI, MICHAEL · 2009 to 2011
$139k
Intramural NIH HHSNCI NIH HHS U01 CA114778NCI NIH HHS UO1-CA 114778NIA NIH HHS F30 AG035484NIA NIH HHS F30AG035484NICHD NIH HHS R01 HD042680NICHD NIH HHS R01HD042680NIGMS NIH HHS GM07739NIGMS NIH HHS T32 GM007739NINDS NIH HHS R01 NS081490NINDS NIH HHS R01NS081490
6 · The paper itself

Abstract

Cell death is a common metazoan cell fate, and its inactivation is central to human malignancy. In Caenorhabditis elegans, apoptotic cell death occurs via the activation of the caspase CED-3 following binding of the EGL-1/BH3-only protein to the antiapoptotic CED-9/BCL2 protein. Here we report a major alternative mechanism for caspase activation in vivo involving the F-box protein DRE-1. DRE-1 functions in parallel to EGL-1, requires CED-9 for activity, and binds to CED-9, suggesting that DRE-1 promotes apoptosis by inactivating CED-9. FBXO10, a human protein related to DRE-1, binds BCL2 and promotes its degradation, thereby initiating cell death. Moreover, some human diffuse large B-cell lymphomas have inactivating mutations in FBXO10 or express FBXO10 at low levels. Our results suggest that DRE-1/FBXO10 is a conserved regulator of apoptosis.

Indexed as

Amino Acid SequenceAnimalsApoptosisBase SequenceCaenorhabditis elegansCaenorhabditis elegans ProteinsCaspasesCell Line, TumorEnzyme ActivationF-Box ProteinsHEK293 CellsHumansLymphomaLymphoma, Large B-Cell, DiffuseMolecular Sequence DataMutation, MissenseCaenorhabditis elegans ProteinsCaspasesced-3 protein, C elegansDRE-1 protein, C elegansEGL-1 protein, C elegansF-Box ProteinsProto-Oncogene Proteins c-bcl-2Repressor ProteinsRNA, MessengerRNA, Neoplasm

Identifiers

PMID23431138
PMCPMC3593917
OpenAlexW2060876398

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.